Patents by Inventor Matti Kivikko

Matti Kivikko has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for administering levosimendan
    Publication number: 20070032557
    Abstract: The invention relates to intermittent administration of an inotropic agent (such as, but not limited to a levosimendan compound) or a pharmaceutically acceptable salt thereof in the treatment of cardiovascular disorders, such as, pulmonary hypertension, myocardial ischemia, acute heart failure, chronic heart failure or acute on chronic heart failure.
    Type: Application
    Filed: February 17, 2006
    Publication date: February 8, 2007
    Inventors: Matti Kivikko, Robert Padley, Roopal Thakkar, Leticia Delgado-Herrera
  • Method for administering levosimendan
    Publication number: 20070010518
    Abstract: The invention relates to intermittent administration of a levosimendan compound or a pharmaceutically acceptable salt thereof in the treatment of cardiovascular disorders such as chronic heart failure. The intermittent dose is more than 0.04 mg/kg and the period between each intermittent dose is 6-30 days, preferably 6-25 days. The administration is suitably, for example, an intermittent intravenous infusion.
    Type: Application
    Filed: February 17, 2006
    Publication date: January 11, 2007
    Inventor: Matti Kivikko
  • Method for treating renal failure
    Publication number: 20060166994
    Abstract: Levosimendan or its active metabolite (II), which have been previously suggested for the treatment of congestive heart failure, are useful in the treatment of renal failure.
    Type: Application
    Filed: January 2, 2004
    Publication date: July 27, 2006
    Inventors: Matti Kivikko, Heimo Haikala